Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: The Swiss Transplant Cohort Study

Transplant International

Volumn 27, Issue 7, 2014, Pages 657-666

  De Geest, Sabina ^a   Burkhalter, Hanna ^a   Bogert, Laura ^a   Berben, Lut ^a   Glass, Tracy R ^b   Denhaerynck, Kris ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

immunosuppressive therapy; medication adherence; post transplant; pretransplant; prospective cohort study

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG DOSE REGIMEN; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LIVER GRAFT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; TREATMENT REFUSAL; AGED; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84902543519     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12312     Document Type: Article

References (40)

1. Dew MA, DiMartini AF, De Vito Dabbs A, et al,. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858.
2. De Geest S, Denhaerynck K, Dobbels F,. Clinical and economic consequences of nonadherence to immunosuppressive drugs in adult solid organ transplantation. Compliance in solid organ transplantation (Invited Editor: Dr. Federico Oppenheimer). In:, Grinyõ J, ed. International Transplantation Updates. Barcelona, Spain: Permanyer Publications, 2011: 63-81.
3. Vlaminck H, Maes B, Evers G, et al,. Prospective study on late consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509.
4. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC,. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769.
5. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR,. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009; 9: 2597.
6. Dobbels F, De Geest S, Cleemput I, et al,. Psychosocial and behavioral selection criteria for solid organ transplantation. Prog Transplant 2001; 11: 121; quiz 31-2.
7. Dobbels F, Verleden G, Dupont L, Vanhaecke J, De Geest S,. To transplant or not? The importance of psychosocial and behavioural factors before lung transplantation. Chron Respir Dis 2006; 3: 39.
8. Dobbels F, Vanhaecke J, Dupont L, et al,. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009; 87: 1497.
9. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP,. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996; 15: 631.
10. Dew MA, Dimartini AF, De Vito Dabbs A, et al,. Adherence to the medical regimen during the first two years after lung transplantation. Transplantation 2008; 85: 193.
11. Nevins TE, Thomas W,. Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation 2009; 87: 711.
12. Couzi L, Moulin B, Morin MP, et al,. Factors predictive of medication nonadherence after Renal transplantation: a French Observational Study. Transplantation 2013; 95: 326.
13. Koller MT, van Delden C, Muller NJ, et al,. Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol 2013; 28: 347.
14. De Geest S, Burkhalter H, Berben L, et al,. The Swiss Transplant Cohort Study's framework for assessing lifelong psychosocial factors in solid-organ transplants. Prog Transplant 2013; 23: 235.
15. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361.
16. Dobbels F, Berben L, De Geest S, et al,. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation 2010; 90: 205.
17. Marsicano Ede O, Fernandes Nda S, Colugnati F, et al,. Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrol 2013; 14: 108.
18. Ducci J, De Simone P, Denhaerynck K, Dobbels F, De Geest S,. Clinical consequences of subclinical non adherence to immunosuppression after liver transplantation. Transplant Int 2013; 26 (Suppl. 2): 146.
19. Glass TR, De Geest S, Weber R, et al,. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2006; 41: 385.
20. Glass TR, De Geest S, Hirschel B, et al,. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther 2008; 13: 77.
21. Deschamps AE, De Geest S, Vandamme AM, Bobbaers H, Peetermans WE, Van Wijngaerden E,. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS 2008; 22: 735.
22. Villa L, Abraham I, MacDonald K, Denhaerynck K,. Correlation of physician-rated adherence with therapeutical outcomes in antihypertensive treatment: pooled analysis findings from six valsartan studies including 15,583 available patients. Value in Health 2011; 14: A383.
23. Dobbels F, De Geest S,. How to identify nonadherence to immunosuppressive medication in organ transplant recipients? Current insights and future challenges.Compliance in solid organ transplantation (Invited Editor: Dr. Federico Oppenheimer). In:, Grinyõ J, ed. Included in the Series International Transplantion Updates 2011. Barcelona, Spain: Permanyer Publications, 2011: 1-19.
24. Zeger SL, Liang KY,. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121.
25. Nevins TE, Kruse L, Skeans MA, Thomas W,. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565.
26. Chisholm MA, Vollenweider LJ, Mulloy LL, et al,. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000; 70: 1240.
27. Dobbels F, Vanhaecke J, Desmyttere A, Dupont L, Nevens F, De Geest S,. Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates. Transplantation 2005; 79: 1588.
28. Dobbels F, Vanhaecke J, Nevens F, et al,. Liver versus cardiothoracic transplant candidates and their pretransplant psychosocial and behavioral risk profiles: good neighbors or complete strangers? Transpl Int 2007; 20: 1020.
29. Simpson SH, Eurich DT, Majumdar SR, et al,. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
30. Goetzmann L, Ruegg L, Stamm M, et al,. Psychosocial profiles after transplantation: a 24-month follow-up of heart, lung, liver, kidney and allogeneic bone-marrow patients. Transplantation 2008; 86: 662.
31. Germani G, Lazzaro S, Gnoato F, et al,. Nonadherent behaviors after solid organ transplantation. Transplant Proc 2011; 43: 318.
32. Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E,. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation 2012; 93: 958.
33. Sankaranarayanan J, Collier D, Furasek A, et al,. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients. Res Social Adm Pharm 2012; 8: 228.
34. De Bleser L, Dobbels F, Berben L, et al,. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int 2011; 24: 882.
35. Morales JM, Varo E, Lazaro P,. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transplant 2012; 26: 369.
36. Dharancy S, Giral M, Tetaz R, Fatras M, Dubel L, Pageaux GP,. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin Transplant 2012; 26: E293.
37. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S,. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int 2009; 22: 780.
38. De Geest S, Burkhalter H, De Bleser L, et al,. Nonadherence to immunosuppressive drugs in transplantation: what can clinicians do? J Renal Nurs 2010; 2: 59.
39. Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S,. Diagnostic accuracy of measurement methods to assess nonadherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008; 8: 616.
40. De Geest S, Abraham I, Moons P, et al,. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant 1998; 17: 854.